Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

Kulmira Nurgali^{1

2}, R Thomas Jagoe³, Raquel Abalo^{4

5

6

7}

Affiliations

¹ College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
² Department of Medicine, Western Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Regenerative Medicine and Stem Cells Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC, Australia.
³ McGill Cancer Nutrition Rehabilitation Program and the Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.
⁴ Área de Farmacología y Nutrición, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
⁵ Unidad Asociada I+D+i del Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
⁶ Unidad Asociada I+D+i del Instituto de Investigación en Ciencias de la Alimentación (CIAL), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
⁷ Grupo de Excelencia Investigadora URJC, Banco de Santander, Grupo Multidisciplinar de Investigación y Tratamiento del Dolor (i+DOL), Alcorcón, Spain.

Editorial

Kulmira Nurgali et al. Front Pharmacol. 2018.

. 2018 Mar 22:9:245.

doi: 10.3389/fphar.2018.00245. eCollection 2018.

Kulmira Nurgali^{1

2}, R Thomas Jagoe³, Raquel Abalo^{4

5

6

7}

¹ College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia.
² Department of Medicine, Western Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Regenerative Medicine and Stem Cells Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC, Australia.
³ McGill Cancer Nutrition Rehabilitation Program and the Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.
⁴ Área de Farmacología y Nutrición, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
⁵ Unidad Asociada I+D+i del Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
⁶ Unidad Asociada I+D+i del Instituto de Investigación en Ciencias de la Alimentación (CIAL), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
⁷ Grupo de Excelencia Investigadora URJC, Banco de Santander, Grupo Multidisciplinar de Investigación y Tratamiento del Dolor (i+DOL), Alcorcón, Spain.

No abstract available

Keywords: adverse effects; antineoplastic drugs; cancer treatment; chemotherapy; toxicity.

Comment on

Editorial on the Research Topic Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

1. Abalo R., Uranga J. A., Pérez-García I., de Andrés R., Girón R., Vera G., et al. (2017). May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat. Neurogastroenterol. Motil. 29:e12952. 10.1111/nmo.12952 - DOI - PubMed
1. Andrews P. L., Sanger G. J. (2014). Nausea and the quest for the perfect anti-emetic. Eur. J. Pharmacol. 722, 108–121. 10.1016/j.ejphar.2013.09.072 - DOI - PubMed
1. Cupit-Link M. C., Kirkland J. L., Ness K. K., Armstrong G. T., Tchkonia T., LeBrasseur N. K., et al. (2017). Biology of premature ageing in survivors of cancer. ESMO Open 2:e000250. 10.1136/esmoopen-2017-000250 - DOI - PMC - PubMed
1. Younus J., Kligman L., Jawaid D. (2016). The impact of cold therapy on the incidence and severity of paclitaxel induced peripheral neuropathy: A pilot study. Journal of Solid Tumors. 6, 43–47. 10.5430/jst.v6n2p43 - DOI
1. Zhou Y. Q., Liu D. Q., Chen S. P., Sun J., Zhou X. R., Rittner H., et al. (2018). Reactive oxygen species scavengers ameliorate mechanical allodynia in a rat model of cancer-induced bone pain. Redox Biol. 14, 391–397. 10.1016/j.redox.2017.10.011 - DOI - PMC - PubMed